Your browser doesn't support javascript.
loading
Refractory de novo myeloid sarcoma: a case report and therapeutic strategy based on bone marrow minimal residual disease.
Inoue, Daichi; Nagai, Yuya; Kimura, Takaharu; Shimoji, Sonoko; Mori, Minako; Togami, Katsuhiro; Tabata, Sumie; Kurata, Masayuki; Matsushita, Akiko; Ito, Kiminari; Hashimoto, Hisako; Maruoka, Hayato; Yamashita, Eiko; Nagai, Kenichi; Imai, Yukihiro; Shirane, Hirohumi; Takahashi, Takayuki.
Afiliação
  • Inoue D; Department of Hematology and Clinical Immunology, Kobe City Medical Center General Hospital, 4-6 Minatojima nakamachi, Chuo-ku, Kobe, 650-0046, Japan. daichi@kcgh.gr.jp.
  • Nagai Y; Department of Hematology and Clinical Immunology, Kobe City Medical Center General Hospital, 4-6 Minatojima nakamachi, Chuo-ku, Kobe, 650-0046, Japan.
  • Kimura T; Department of Hematology and Clinical Immunology, Kobe City Medical Center General Hospital, 4-6 Minatojima nakamachi, Chuo-ku, Kobe, 650-0046, Japan.
  • Shimoji S; Department of Hematology and Clinical Immunology, Kobe City Medical Center General Hospital, 4-6 Minatojima nakamachi, Chuo-ku, Kobe, 650-0046, Japan.
  • Mori M; Department of Hematology and Clinical Immunology, Kobe City Medical Center General Hospital, 4-6 Minatojima nakamachi, Chuo-ku, Kobe, 650-0046, Japan.
  • Togami K; Department of Hematology and Clinical Immunology, Kobe City Medical Center General Hospital, 4-6 Minatojima nakamachi, Chuo-ku, Kobe, 650-0046, Japan.
  • Tabata S; Department of Hematology and Clinical Immunology, Kobe City Medical Center General Hospital, 4-6 Minatojima nakamachi, Chuo-ku, Kobe, 650-0046, Japan.
  • Kurata M; Department of Hematology and Clinical Immunology, Kobe City Medical Center General Hospital, 4-6 Minatojima nakamachi, Chuo-ku, Kobe, 650-0046, Japan.
  • Matsushita A; Department of Hematology and Clinical Immunology, Kobe City Medical Center General Hospital, 4-6 Minatojima nakamachi, Chuo-ku, Kobe, 650-0046, Japan.
  • Ito K; Department of Cell Therapy, Institute of Biomedical Research and Innovation, Kobe, Japan.
  • Hashimoto H; Department of Cell Therapy, Institute of Biomedical Research and Innovation, Kobe, Japan.
  • Maruoka H; Department of Clinical Laboratory, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Yamashita E; Department of Clinical Laboratory, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Nagai K; Department of Hematology and Clinical Immunology, Kobe City Medical Center General Hospital, 4-6 Minatojima nakamachi, Chuo-ku, Kobe, 650-0046, Japan.
  • Imai Y; Department of Pathology, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Shirane H; Department of Pathology, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Takahashi T; Department of Hematology and Clinical Immunology, Kobe City Medical Center General Hospital, 4-6 Minatojima nakamachi, Chuo-ku, Kobe, 650-0046, Japan.
Int J Hematol ; 90(1): 120-123, 2009 Jul.
Article em En | MEDLINE | ID: mdl-19513804
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Neoplasias da Medula Óssea / Sarcoma Mieloide / Neoplasias de Cabeça e Pescoço Idioma: En Ano de publicação: 2009 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Neoplasias da Medula Óssea / Sarcoma Mieloide / Neoplasias de Cabeça e Pescoço Idioma: En Ano de publicação: 2009 Tipo de documento: Article